查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969153

液態醫用黏合劑市場：依產品類型、應用、最終用戶、通路分類，全球預測（2026-2032年）

Liquid Medical Adhesives Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

液体医療用黏合劑市場は、2025年に122億9,000万米ドルと評価され、2026年には131億2,000万米ドルに成長し、CAGR 7.35％で推移し、2032年までに202億1,000万米ドルに達すると予測されています。

主要市場統計數據
基準年 2025 122.9億美元
預計年份：2026年 131.2億美元
預測年份 2032 202.1億美元
複合年成長率 (%) 7.35%

了解聚合物化學的進步和臨床重點如何重新定義液體醫用黏合劑在整個護理路徑和整個醫療設備生態系統中的作用。

液態醫用黏合劑正逐漸成為現代醫療流程中一項至關重要的基礎技術，彌合了醫療設備設計、傷口管理和以病人為中心的照護之間的鴻溝。這些化學技術能夠實現快速黏合、與皮膚和醫用基材的強力黏合，並具有生物相容性，使其成為對無縫線閉合、醫療設備固定和牢固的穿戴式介面至關重要的應用的理想選擇。聚合物科學、表面化學和黏合劑固化製程的進步拓展了其功能，即使在潮濕環境、移動條件和長期配戴條件下，也能確保可靠的黏合性能。

了解材料創新、臨床工作流程的演變和永續性這三種力量的融合，以重建滿足現代醫學需求的液態醫用黏合劑。

液態醫用黏合劑領域正經歷著一場變革，其驅動力包括技術創新、臨床工作流程的演變以及患者期望的不斷提高。包括更先進的丙烯酸酯、氰基丙烯酸酯衍生物和矽酮配方在內的新型化學技術，使得黏合劑能夠兼具即時固定和溫和移除的特性，從而拓展了其在敏感肌膚和慢性傷口患者中的應用範圍。同時，與智慧型穿戴裝置和藥物輸送貼片的整合也對黏合劑，例如保持感測器的精確度、透氣性和可控的配戴時間。

本檢驗了近期美國關稅調整如何促使整個黏合劑價值鏈進行策略性採購轉移、成本控制措施和彈性規劃。

美國近期關稅政策的變化和貿易政策決策為原料和成品黏合劑供應商帶來了新的商業風險和營運複雜性。關稅調整影響上游聚合物供應商、特殊單體生產商以及底漆和包裝材料等輔助組件。因此，採購部門正在重新評估其籌資策略，包括近岸外包、多供應商認證和重新談判框架協議，以緩解利潤壓力和交貨不確定性。

在液態醫用黏合劑領域創造差異化機會：探索產品化學、臨床應用、終端用戶優先事項和通路的交集。

市場區隔揭示了臨床需求、材料性能和分銷物流的交匯點，從而創造了差異化機會。基於產品類型的創新優先開發具有廣泛黏合性能的丙烯酸酯黏合劑、用於快速組織黏合的氰基丙烯酸酯黏合劑、適用於傷口滲出液管理的親水膠體黏合劑、具有優異延展性和耐久性的聚氨酯黏合劑，以及對皮膚溫和且提供卓越長期舒適度的矽酮黏合劑。這些材料特性會影響配方路線，使每種產品類型都能針對其最佳應用進行最佳化。

我們將評估美洲、歐洲、中東和非洲以及亞太地區的區域管理體制、醫療保健基礎設施和採購政策如何影響產品引進和商業化策略。

區域趨勢凸顯了管理體制、醫療基礎設施和在地採購趨勢如何驅動不同管道的採用。在美洲，先進的醫院系統、高門診量以及對居家醫療日益成長的重視正在塑造市場需求。在這種環境下，那些在縮短治療時間和提高患者舒適度方面展現出明顯臨床優勢的黏合劑更具優勢，而商業模式往往強調與醫療服務提供者的直接合作以及集中式分銷網路。

該評估旨在評估材料創新、監管專業知識和策略夥伴關係如何創造液態醫用黏合劑領域的競爭優勢和領導地位。

醫療設備原始設備製造商 (OEM)、特殊黏合劑製造商和契約製造組織 (CMO) 之間的材料創新、垂直整合和策略聯盟的整合，共同塑造了當前的競爭格局。主要企業憑藉其專有的化學技術脫穎而出，這些技術能夠平衡黏合強度和皮膚親和性；此外，它們還擁有高效的生產平台，確保產品品質的穩定性；同時，它們也具備豐富的法規遵從經驗，能夠加速臨床應用。與醫療設備製造商和臨床研究合作夥伴建立策略聯盟的情況日益普遍，這使得企業能夠共同開發整合式黏合劑和醫療設備，以及針對特定應用的證據包。

為了在利用黏合劑的醫療應用領域實現永續成長，必須採取切實可行的藍圖，將材料創新、強大的採購系統和加速的臨床檢驗相結合。

領導企業應優先採取三管齊下的策略：材料和使用者體驗創新、增強供應鏈韌性以及加快臨床檢驗。投資於兼具強黏合性和微創移除能力的先進化學技術，將有助於應對最緊迫的臨床挑戰，並開拓新的應用領域。同時，設計中應考慮透氣性、低致敏性和感測器相容性等以患者為中心的因素，以確保產品在從門診護理到居家醫療等各種環境下都能可靠使用。

了解我們如何透過結合技術文獻、監管分析和相關人員訪談的多源調查方法，對黏合劑產業進行穩健且可重複的評估。

本分析的研究結合了對公開科學文獻、監管文件和專利概況的系統性回顧，以及對整個黏合劑和醫療設備生態系統的結構化訪談和基於一手資料的討論。技術文獻提供了有關聚合物化學、固化機制和生物相容性測試標準的背景資訊，而監管文件則闡明了主要司法管轄區的核准流程和上市後監管要求。

為了最大限度地發揮液態醫用黏合劑的潛力，我們整合了技術卓越性、臨床證據和穩健營運必須協同運作的策略要求。

液態醫用黏合劑有望在現代醫學中發揮日益重要的作用，實現無縫合、牢固的醫療設備固定以及舒適易用的佩戴式介面。材料科學的進步，加上臨床應用模式的不斷擴展，正推動其在導管固定、藥物傳輸貼片、電極固定、造口裝置和外科性創傷閉合等諸多領域中廣泛應用。同時，隨著終端使用者轉向門診和居家醫療，對能夠在傳統臨床環境之外可靠發揮作用的黏合劑的需求也日益成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 液態醫用黏合劑市場：依產品類型分類

  • 丙烯酸黏合劑
  • 氰基丙烯酸黏合劑
  • 親水膠體黏合劑
  • 聚氨酯黏合劑
  • 矽膠黏合劑

第9章 液態醫用黏合劑市場：依應用領域分類

  • 導管固定
  • 藥物輸送貼片
  • 固定電極
  • 造口用品
  • 外科性創傷閉合

第10章 液態醫用黏合劑市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院和診所
  • 研究所

第11章 液態醫用黏合劑市場：按分銷管道分類

  • 直銷
  • 銷售代理
  • 線上銷售

第12章 液態醫用黏合劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 液態醫用黏合劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 液態醫用黏合劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國：液態醫用黏合劑市場

第16章 中國：液態醫用黏合劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Arkema SA
  • Ashland Global Holdings Inc.
  • Avery Dennison Corporation
  • Dow Inc.
  • Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • Evonik Industries AG
  • HB Fuller Company
  • Henkel AG & Co. KGaA
  • Nitto Denko Corporation
  • Panacol-Elosol GmbH
  • Permabond LLC
  • Scapa Group plc
Product Code: MRR-535C6291840B

The Liquid Medical Adhesives Market was valued at USD 12.29 billion in 2025 and is projected to grow to USD 13.12 billion in 2026, with a CAGR of 7.35%, reaching USD 20.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.29 billion
Estimated Year [2026] USD 13.12 billion
Forecast Year [2032] USD 20.21 billion
CAGR (%) 7.35%

Explore how advances in polymer chemistry and clinical priorities are redefining the role of liquid medical adhesives across care pathways and device ecosystems

Liquid medical adhesives are emerging as essential enablers across modern healthcare pathways, bridging gaps between device design, wound management, and patient-centric care. These chemistries deliver rapid adhesion, conformability to skin and medical substrates, and formulations tuned for biocompatibility, making them well suited for applications where sutureless closure, device fixation, and secure wearable interfaces matter. Advances in polymer science, surface chemistry, and adhesive curing processes have expanded the functional envelope, enabling adhesives to perform reliably under moisture, movement, and extended wear conditions.

Clinicians and device developers increasingly prioritize adhesives that reduce procedure time, lower infection risk, and improve cosmetic outcomes. Consequently, innovation has trended toward formulations that balance shear and peel strength with gentle removal profiles and reduced skin irritation. Regulatory scrutiny has intensified in parallel, prompting manufacturers to invest in robust biocompatibility testing, adhesive-device compatibility assessments, and clinical evidence demonstrating safety and performance.

From an operational perspective, adhesives are influencing care delivery beyond the hospital. The growth of ambulatory procedures, home-based wound care, and wearable therapeutic systems demands adhesives that are simple to apply, provide consistent performance in non-sterile environments, and integrate with remote monitoring. As a result, the technology roadmap now reflects a convergence of material science, user-centered design, and regulatory strategy that positions liquid medical adhesives as a critical component of next-generation medical device ecosystems.

Understand the converging forces of material innovation, clinical workflow evolution, and sustainability that are reshaping liquid medical adhesives for modern healthcare demands

The landscape for liquid medical adhesives is undergoing transformative shifts driven by technological innovation, evolving clinical workflows, and heightened patient expectations. Emerging chemistries, including more sophisticated acrylic systems, cyanoacrylate derivatives, and silicone-based formulations, are enabling adhesives that combine immediate fixation with gentler removal, thereby expanding their suitability across delicate skin types and chronic wound populations. Concurrently, integration with smart wearables and drug delivery patches has created new functional requirements for adhesives to support sensor fidelity, breathability, and controlled wear times.

Health systems are also recalibrating procedural pathways toward minimally invasive and outpatient care, which elevates the importance of adhesive solutions that reduce time in clinic and simplify postoperative management. This shift is complemented by increasing adoption of remote patient monitoring, wherein adhesives must maintain adhesion under day-to-day activities while preserving skin integrity. Supply chain resilience and sustainability considerations are further shaping formulation and packaging choices, prompting manufacturers to explore recyclable substrates, reduced solvent footprints, and streamlined logistics.

Regulatory and reimbursement environments are adjusting to these changes. Manufacturers now face expectations for higher levels of clinical evidence and post-market surveillance, which in turn incentivizes partnerships between adhesive suppliers, device OEMs, and clinical investigators. Altogether, these forces are driving a more integrated, performance-driven market where material innovation, clinical validation, and end-user usability determine competitive differentiation.

Examine how recent U.S. tariff adjustments are prompting strategic sourcing shifts, cost management measures, and resilience planning across adhesive value chains

Recent tariff developments and trade policy decisions in the United States have introduced a new vector of commercial risk and operational complexity for companies sourcing raw materials and finished adhesive products. Tariff adjustments affect upstream polymer suppliers, specialty monomer producers, and ancillary components such as primers and packaging materials. As a result, procurement teams are reassessing sourcing strategies, including nearshoring, multi-supplier qualification, and renegotiated framework agreements to mitigate margin pressure and delivery uncertainty.

In response, manufacturers are implementing a variety of cost-containment and resilience measures. These include optimizing bill-of-materials for lower-cost alternatives where regulatory impact is minimal, increasing inventory buffers for critical components, and accelerating qualification of alternative supply nodes. At the same time, companies are enhancing cost-transparency measures across the value chain to quantify the direct and indirect impacts of tariff changes on pricing strategies and customer contracts.

Strategic responses also emphasize regulatory alignment and risk management. Organizations are combining tariff scenario planning with regulatory pathway assessments to ensure that any substitution of raw materials or change of manufacturing location does not compromise compliance. The result is a more disciplined approach to supplier diversification, contractual safeguards, and long-term sourcing roadmaps that balance commercial agility with product integrity and patient safety.

Discover how product chemistry, clinical application, end-user priorities, and distribution pathways intersect to create differentiated opportunities in liquid medical adhesives

Segmentation reveals where clinical need, material performance, and distribution logistics intersect to create differentiated opportunities. Based on product type, innovation prioritizes acrylic adhesives for broad adhesion profiles, cyanoacrylate adhesives for rapid tissue bonding, hydrocolloid adhesives for wound exudate management, polyurethane adhesives for extensibility and robustness, and silicone adhesives for gentle skin contact and long-wear comfort. These material distinctions influence formulation pathways and shape which applications each product class best serves.

Based on application, the adhesive requirements vary substantially. Catheter fixation demands secure, low-profile bond lines that tolerate patient movement, while drug delivery patches require adhesives that maintain adhesion without compromising drug permeation and sensor contact. Electrode fixation prioritizes consistent skin contact and electrical conduction stability, ostomy appliances need adhesives that can sustain adhesion over irregular surfaces and extended wear, and surgical wound closure applications demand precise bonding performance with validated biocompatibility.

Based on end user, performance and procurement priorities shift. Ambulatory surgical centers favor solutions that reduce procedure time and simplify inventory, home healthcare emphasizes ease-of-use and patient comfort for non-clinical application, hospitals and clinics require robust evidence of performance under diverse patient populations, and research laboratories demand quality-assured materials suitable for testing and innovation. Based on distribution channel, manufacturers must tailor commercial strategies to direct sales relationships for bundled device-adherent systems, distributor partnerships for scale and reach, online sales for convenience and rapid replenishment, and retail pharmacies where consumer-oriented products must meet shelf-ready packaging and regulatory labeling expectations.

Taken together, these segmentation lenses clarify how product chemistry, clinical use case, end-user workflows, and distribution pathways coalesce to shape go-to-market strategies and R&D prioritization.

Assess how regional regulatory regimes, care infrastructure, and procurement preferences in the Americas, EMEA, and Asia-Pacific shape adoption and commercialization strategies

Regional dynamics underscore how regulatory regimes, healthcare infrastructure, and local procurement preferences drive divergent adoption trajectories. In the Americas, demand is shaped by a mix of advanced hospital systems, high ambulatory procedure volumes, and a growing emphasis on home-based care. These conditions favor adhesives that demonstrate clear clinical benefits in reducing procedure time and improving patient comfort, while commercial models often emphasize direct engagement with healthcare providers and centralized distribution networks.

In Europe, the Middle East & Africa, regulatory rigor, varied reimbursement frameworks, and heterogeneous care settings lead to differentiated product adoption. Western European markets often require extensive clinical evidence and adherence to stringent quality systems, whereas markets within the broader region may prioritize cost-effective solutions and adaptable distribution models. Manufacturers operating in this region must navigate complex regulatory pathways and design modular commercial approaches that reflect both high-compliance markets and price-sensitive environments.

In the Asia-Pacific region, rapid healthcare infrastructure expansion, rising outpatient procedures, and an increasing focus on medical device innovation create substantial demand for versatile adhesive solutions. Local manufacturing capabilities and government-driven initiatives to enhance domestic production can influence sourcing and partnership strategies. Across these regions, companies will need to align regulatory preparedness, localized clinical evidence generation, and tailored commercial models to capture opportunities while managing operational complexity.

Evaluate how material innovation, regulatory expertise, and strategic partnerships create competitive advantage and define leadership in the liquid medical adhesive sector

Competitive dynamics are driven by a blend of material innovation, vertical integration, and strategic partnerships across medical device OEMs, specialty adhesive manufacturers, and contract manufacturing organizations. Leading players differentiate through proprietary chemistries that balance adhesive strength with skin gentleness, scale-efficient manufacturing platforms that support consistent quality, and regulatory experience that accelerates clinical adoption. Strategic collaborations with device makers and clinical research partners are increasingly common, enabling co-development of adhesive-device assemblies and evidence packages for targeted applications.

Apart from core chemistry and regulatory capabilities, companies that excel invest in application-specific testing facilities, human factors research, and real-world performance studies. These investments build commercial credibility and reduce adoption friction among clinicians. Firms also explore downstream value-adds such as customized application systems, pre-applied adhesive interfaces on medical devices, and integrated supply solutions that bundle adhesives with device delivery kits. Mergers, acquisitions, and licensing agreements remain viable routes to expand technology portfolios and geographic reach, particularly where local regulatory expertise or production capacity is a differentiator.

Market leaders focus on operational excellence, reproducible quality systems, and clear post-market surveillance processes. Equally important is the ability to articulate clinical and economic value to procurement stakeholders, demonstrating how adhesive-enabled workflows reduce procedure time, lower complication rates, or improve patient satisfaction. This combination of technical strength and commercial clarity defines competitive advantage in the evolving adhesive landscape.

Adopt a pragmatic roadmap that blends material innovation, resilient sourcing, and accelerated clinical validation to capture sustainable growth in adhesive-enabled healthcare applications

Leaders should prioritize a three-pronged approach: innovate across materials and user experience, fortify supply chain resilience, and accelerate clinical validation. Investing in advanced chemistries that reconcile strong adhesion with atraumatic removal will address the most pressing clinical pain points and open new application areas. Simultaneously, design efforts should incorporate patient-centered considerations such as breathability, hypoallergenicity, and compatibility with sensors to ensure broad usability across ambulatory and home-care settings.

On the operational front, diversify sourcing strategies to reduce exposure to single-source suppliers and tariff-driven cost shocks. Establish dual-source qualifications, nearshore manufacturing options, and strategic inventory optimization to maintain service levels without compromising product integrity. Parallel to these actions, embed regulatory risk management into the early stages of product development, ensuring that material substitutions, manufacturing changes, or new packaging formats are validated through targeted biocompatibility and human factors studies.

Finally, accelerate clinical evidence generation through pragmatic trials and real-world evidence initiatives that validate value propositions for clinicians and procurement teams. Use these data to craft compelling health economic narratives that resonate with payers and hospital administrators. Pursue collaborative commercialization models with device OEMs and healthcare providers that align incentives and streamline adoption. Taken together, these actions will strengthen market positioning, reduce operational vulnerability, and support sustainable growth.

Learn how a multi-source methodology combining technical literature, regulatory analysis, and stakeholder interviews produced a robust and reproducible assessment of the adhesive landscape

The research underpinning this analysis combined a systematic review of publicly available scientific literature, regulatory filings, and patent landscapes with structured interviews and primary discussions across the adhesive and medical device ecosystem. Technical literature provided context on polymer chemistries, curing mechanisms, and biocompatibility testing standards, while regulatory documents helped map approval pathways and post-market surveillance expectations in major jurisdictions.

Primary insights were derived from interviews with a cross-section of stakeholders, including clinicians, device engineers, procurement leaders, and manufacturing specialists. These discussions illuminated practical performance requirements, procurement criteria, and operational constraints that influence selection and deployment of adhesive solutions. In addition, supply chain and trade policy analyses were incorporated to contextualize sourcing risks and tariff-related impacts on component availability.

Throughout the research process, findings were triangulated across multiple evidence streams to ensure robustness. Where qualitative differences emerged, they were explored through follow-up interviews and comparison with regulatory precedent. The methodology emphasized reproducibility and transparency in evidence synthesis, enabling readers to understand the provenance of conclusions and the boundaries of inference for strategic decision-making.

Synthesize the strategic imperative that technical excellence, clinical evidence, and resilient operations must align to realize the full potential of liquid medical adhesives

Liquid medical adhesives are poised to play an increasingly central role in modern healthcare by enabling sutureless closure, secure device fixation, and comfortable wearable interfaces. Advances in material science and clinical adoption patterns are converging to expand application breadth across catheter fixation, drug delivery patches, electrode fixation, ostomy appliances, and surgical wound closure. Meanwhile, end-user shifts toward ambulatory and home-based care are amplifying the need for adhesives that perform reliably outside traditional clinical environments.

Operational pressures such as tariffs, supply chain volatility, and regulatory expectations are prompting manufacturers to adopt more disciplined sourcing and evidence-generation strategies. Success will depend on the ability to combine differentiated chemistries with rigorous clinical validation and adaptive commercial models that reflect regional regulatory and reimbursement realities. Companies that invest in integrated product development, resilient manufacturing networks, and clear value communication will be best positioned to translate technological promise into clinical and commercial outcomes.

In sum, the adhesive sector offers tangible opportunities for innovation and growth, but realizing them will require coordinated action across R&D, regulatory, supply chain, and commercial functions. The most successful organizations will be those that align technical excellence with pragmatic deployment strategies to meet the evolving needs of clinicians, patients, and healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Liquid Medical Adhesives Market, by Product Type

  • 8.1. Acrylic Adhesives
  • 8.2. Cyanoacrylate Adhesives
  • 8.3. Hydrocolloid Adhesives
  • 8.4. Polyurethane Adhesives
  • 8.5. Silicone Adhesives

9. Liquid Medical Adhesives Market, by Application

  • 9.1. Catheter Fixation
  • 9.2. Drug Delivery Patches
  • 9.3. Electrode Fixation
  • 9.4. Ostomy Appliances
  • 9.5. Surgical Wound Closure

10. Liquid Medical Adhesives Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals & Clinics
  • 10.4. Research Laboratories

11. Liquid Medical Adhesives Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Sales

12. Liquid Medical Adhesives Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Liquid Medical Adhesives Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Liquid Medical Adhesives Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Liquid Medical Adhesives Market

16. China Liquid Medical Adhesives Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Arkema S.A.
  • 17.7. Ashland Global Holdings Inc.
  • 17.8. Avery Dennison Corporation
  • 17.9. Dow Inc.
  • 17.10. Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • 17.11. Evonik Industries AG
  • 17.12. H.B. Fuller Company
  • 17.13. Henkel AG & Co. KGaA
  • 17.14. Nitto Denko Corporation
  • 17.15. Panacol-Elosol GmbH
  • 17.16. Permabond LLC
  • 17.17. Scapa Group plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIQUID MEDICAL ADHESIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY POLYURETHANE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY POLYURETHANE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY POLYURETHANE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CATHETER FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CATHETER FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CATHETER FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DRUG DELIVERY PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DRUG DELIVERY PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DRUG DELIVERY PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY OSTOMY APPLIANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY OSTOMY APPLIANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY OSTOMY APPLIANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SURGICAL WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SURGICAL WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SURGICAL WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)